Invenra

company

About

Invenra operates as a biotechnology company focused on early stage drug discovery.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$4.01M
Industries
Biotechnology,Life Science,Medical,Pharmaceutical
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Invenra is focused on discovering the next generation of best-in-class biologics, with an emphasis on antibodies and their derivatives. The company's proprietary technology combines the cell-free expression of full-length antibodies and extreme miniaturization, enabling the screening of unprecedented numbers of full-length antibodies in phenotypic assays.

Invenra touts a broad scientific foundation and a team of scientists with deep expertise in key areas ranging from genomics to biochemistry to bioengineering. Their background is well balanced between cutting edge basic research and commercial products and services.

The company was established in 2011 and is based in Madison, Wisconsin, United States.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$12.96M
Invenra has raised a total of $12.96M in funding over 2 rounds. Their latest funding was raised on Oct 3, 2017 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 3, 2017 Series Unknown $2.93M 1 Detail
Jul 20, 2016 Series Unknown $3.01M 1 Detail
May 24, 2016 Series Unknown $4.01M 1 Detail
Feb 20, 2013 Series Unknown $3M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Invenra is funded by 1 investors. NEW Capital Fund are the most recent investors.
Investor Name Lead Investor Funding Round
NEW Capital Fund Series Unknown